Form D · Biotechnology
Kraig Biocraft Laboratories, Inc
Ann Arbor, MI · CIK 0001413119
Offering snapshot reported Feb 1, 2022 · SEC filing
- Reported sold
- $8M Offering amount: $8M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- Dec 11, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2022 | Initial | $8,000,000 | No comparison | 1 | SEC filing |
| Nov 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $630K
- Finders' fees
- $0
- Form D file number
- 021-431761
Convertible Note + Warrants
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Maxim Group LLC | 120708 |
Source: Form D, filed Feb 1, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kim Thompson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2723 South State Street Suite 150
Ann Arbor, MI, 48104
Ann Arbor, MI, 48104